Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: Experience in a paediatric population

Developmental Medicine and Child Neurology

Volumn 47, Issue 7, 2005, Pages 443-448

  Gassió, Rosa ^a   Artuch, Rafael ^a   Vilaseca, Maria Antonia ^a   Fusté, Eugenia ^a   Boix, Cristina ^a   Sans, Anna ^a   Campistol, Jaume ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE; TYROSINE;

ADOLESCENT; ARTICLE; BRAIN FUNCTION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERPHENYLALANINEMIA; MALE; MENTAL PERFORMANCE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PHENYLKETONURIA; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ATTENTION; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, ION EXCHANGE; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTELLIGENCE; MALE; NEUROPSYCHOLOGICAL TESTS; PHENYLALANINE; PHENYLKETONURIAS; PROBLEM SOLVING; PSYCHOMOTOR PERFORMANCE; SPATIAL BEHAVIOR; STATISTICS, NONPARAMETRIC; TYROSINE; VERBAL BEHAVIOR; VISUAL PERCEPTION;

EID: 21244501270     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0012162205000861     Document Type: Article

References (37)

1. Anderson PJ, Wood SJ, Francis DE, Coleman L, Warwick L, Casanelia S, Anderson VA, Boneh A. (2004) Neuropsychological functioning in children with early-treated phenylketonuria: impact of white matter abnormalities. Dev Med Child Neurol 46: 230-238.
2. Arnold GL, Kramer BM, Kirby RS, Plumeau PB, Blakely EM, Sanger Cregan LS, Davidson PW. (1998) Factors affecting cognitive, motor, behavioural and excutive functioning in children with phenylketonuria. Acta Paediatr 87: 565-570.
3. Bauman ML, Kemper TL. (1982) Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol 58: 55-63.
4. Burgard P. (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159 (Suppl. 2): S74-S79.
5. Conners CK. (1995) CPT. Conners' continuous Performance Test. North Tonawanda, NY USA: Multi-Health Systems.
6. Costello PM, Beasley MG, Tillotson SL, Smith I. (1994) Intelligence in mild atypical phenylketonuria. Eur J Pediatr 153: 260-263.
7. Diamond A, Prevor MB, Callender G, Druin D. (1997) Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monogr Soc Res Child Dev 62: 1-208.
8. Dyer CA. (1999) Pathophysiology of phenylketonuria. MRDD Research Reviews 5: 104-112.
9. Feldman R, Denecke J, Pietsch M, Grenzebach M, Weglage J. (2002) Phenylketonuria: no specific frontal lobe-dependent neuropsychological deficits of early-treated patients in comparison with diabetics. Pediatr Res 51: 761-765.
10. Golden CHJ. (1994) Stroop. Test de Colores y Palabras. Madrid: TEA ediciones.
11. Griffiths P, Tarrini M, Robinson P. (1997) Executive function and psychosocial adjustment in children with early treated phenylketonuria: correlation with historical and concurrent phenylalanina levels. J Intellect Disabil Res 41: 317-323.
12. Guldberg P, Rey F, Zschocke J, Romano V, Francois B, Michelis L, Ullrich K, Hoffmann GF, Burgard P, Schmidt H, Meli C, Riva E, Dianzani I, Ponzone A, Rey J, Guttler F. (1998) A European multicentre study of phenylalanine hydroxylase deficiency: classification of 105 nutaions and a general system for genotyped-based prediction of metabolic phenotype. Am J Hum Genet 63: 71-79.
13. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G. (1997) WCST. Test de Clasificación de Tarjetas de Wisconsin. Madrid: TEA ediciones.
14. Huijbregts SCJ, Sonneville LMJ, Licht R, van Spronsen FJ, Verkerk PH, Sergeant JA. (2002) Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia 40: 7-15.
15. Huijbregts SCJ, De Sonneville LMJ, Van Spronsen FJ, Berends IE, Licht R, Verkerk PH, Sergeant JA. (2003) Motor function under lower and higher controlled processing demands in early and continuously-treated phenylketonuria. Neuropsychology 17: 369-379.
16. Kaufman AS, Kaufman NL. (1997) K-ABC. Batería de Evaluación de Kaufman para Niños. Madrid: TEA ediciones.
17. Moyano D, Vilaseca MA, Artuch R, Lambruschini N. (1998) Plasma amino acids in anorexia nervosa. Eur J Clin Nutr 52: 684-689.
18. Przyrembel H, Bremer HJ. (2000) Nutrition, physical growth, and bone density in treated phenylketonuria. Eur J Pediatr 159 (Suppl 2): 129-135.
19. Rey A. (1987). Test de Copia de una Figura Compleja. Madrid: TEA ediciones.
20. Schmidt E, Burgard P, Rupp A. (1996) Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria. Eur J Pediatr 155 (Suppl. 1): 82-86.
21. Scriver CR, Kaufman C, Eisensmith RC, Woo SLC. (2001) The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw Hill. 1667-1724.
22. Smith I, Bealey MG, Ades AE. (1990) Intelligence and quality of dietary treatment in phenylketonuria. Arch Dis Child 65: 472-478.
23. Smith ML, Saltzman J, Klim P, Hanley WB, Feigenbaum A, Clarke J. (2000) Neuropsychological Function in Mild Hyperphenylalaninemia. Am J Mental Ret 105: 69-80.
24. Spreen O, Strauss E. (1991) A Compendium of Neuropsychological Tests. Administration, Norms, and Commentary. New-York: Oxford University Press.
25. Stemerdink N, van der Molen MW, Kalverboer AF, van der Meere JJ, Huisman J, de Jong LW, Slijper FME, Verkerk PH, van Spronsen FJ. (1999) Prefrontal dysfunction in early and continuously treated phenylketonuria. Dev Neuropsychol 16: 29-57.
26. Talley JL. (1993) Children's Auditory Verbal Learning Test 2. Odessa, Texas, USA: Psychological Assessment Resources.
27. Waisbren SE, Brown MJ, de Sonneville LMJ, Levy HL. (1994) Review of neuropsychological functioning in treated phenylketonuria: an information processing approach. Acta Paediatr Suppl 407: 98-103.
28. Waisbren SE. (2000) Comments on cognition and intelligence in phenylketonuria. Eur J Pediatr 159 (Suppl. 2): 80-81.
29. Wechsler D. (1994) WISC-R. Escala de Inteligencia de Wechsler Para Niños - Revisada. Madrid: TEA ediciones.
30. Wechsler D. (1999) WAIS-III. Escala de Inteligencia de Wechsler Para Adultos - III. Madrid: TEA ediciones.
31. Weglage J, Pietsch M, Fünders B, Koch HG, Ullrich K. (1995) Neurological findings in early treated phenylketonuria. Acta Paediatr 84: 411-415.
32. Weglage J, Pietsch M, Fünders B, Koch HG, Ullrich K. (1996) Deficits in selective and sustained attention processes in early treated children with phenylketonuria - result of impaired frontal lobe functions? Eur J Pediatr 155: 200-204.
33. Weglage J, Ullrich K, Pietsch M, Fünders B, Güttler F, Harms E. (1997) Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. Pediatr Res 42: 378-384.
34. Weglage J, Pietsch M, Feldman R, Koch HG, Zschocke J, Hoffman G, Muntau-Heger A, Denecke J, Guldberg P, Güttler F, Möller H, Wendel U, Ullrich K, Harms E. (2001) Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia. Pediatr Res 49: 532-536.
35. Welsh MC, Pennington BF, Ozonoff S. (1990) Neuropsychology of early-treated phenylketonuria: specific executive function deficits. Child Dev 61: 1967.
36. Wendel U, Ullrich K, Schmidt H, Batzler U. (1990) Six-year follow up of phenylalanine intakes and plasma phenylalanine concentrations. Eur J Pediatr 149: 13-16.
37. White DA, Nortz MJ, Mandernach T, Huntington K. (2001) Deficits in memory strategy use related to prefrontal dysfunction during early development: evidence from children with phenylketonuria. Neuropsychology 15: 221-229.